Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 96 | 2023 | 3220 | 6.480 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 18 | 2017 | 556 | 2.630 |
Why?
|
Fatigue | 8 | 2021 | 1552 | 2.260 |
Why?
|
Brain | 101 | 2024 | 27120 | 2.140 |
Why?
|
Magnetic Resonance Imaging | 154 | 2024 | 36429 | 2.100 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 11 | 2023 | 254 | 1.810 |
Why?
|
Atrophy | 31 | 2020 | 1633 | 1.600 |
Why?
|
Nerve Fibers, Myelinated | 11 | 2011 | 952 | 1.300 |
Why?
|
Subtraction Technique | 4 | 2011 | 512 | 0.840 |
Why?
|
Disease Progression | 31 | 2022 | 13510 | 0.830 |
Why?
|
Leukoencephalopathies | 5 | 2019 | 256 | 0.800 |
Why?
|
Medial Forebrain Bundle | 1 | 2021 | 43 | 0.740 |
Why?
|
Anti-Anxiety Agents | 1 | 2023 | 397 | 0.700 |
Why?
|
Imaging, Three-Dimensional | 13 | 2018 | 4063 | 0.700 |
Why?
|
Cognition Disorders | 14 | 2015 | 3980 | 0.700 |
Why?
|
Image Interpretation, Computer-Assisted | 15 | 2019 | 3359 | 0.690 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 6 | 2019 | 244 | 0.660 |
Why?
|
Image Processing, Computer-Assisted | 30 | 2018 | 9002 | 0.640 |
Why?
|
Thalamus | 6 | 2024 | 1047 | 0.550 |
Why?
|
Neurofilament Proteins | 4 | 2022 | 336 | 0.520 |
Why?
|
Gait | 7 | 2011 | 814 | 0.520 |
Why?
|
Image Enhancement | 13 | 2020 | 2885 | 0.510 |
Why?
|
Aging | 15 | 2021 | 8711 | 0.500 |
Why?
|
Cerebrovascular Disorders | 4 | 2013 | 1474 | 0.490 |
Why?
|
Mobility Limitation | 4 | 2013 | 408 | 0.450 |
Why?
|
Longitudinal Studies | 29 | 2020 | 14607 | 0.440 |
Why?
|
Spinal Cord | 6 | 2020 | 1819 | 0.440 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2791 | 0.420 |
Why?
|
Reproducibility of Results | 29 | 2023 | 20099 | 0.420 |
Why?
|
Corpus Callosum | 6 | 2018 | 751 | 0.410 |
Why?
|
Male | 137 | 2023 | 360842 | 0.390 |
Why?
|
Gait Disorders, Neurologic | 2 | 2011 | 240 | 0.390 |
Why?
|
Physicians' Offices | 1 | 2011 | 60 | 0.380 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1248 | 0.380 |
Why?
|
Diffusion Tensor Imaging | 10 | 2018 | 2400 | 0.380 |
Why?
|
Humans | 188 | 2024 | 761572 | 0.370 |
Why?
|
Neuropsychological Tests | 18 | 2016 | 7054 | 0.370 |
Why?
|
Nerve Regeneration | 2 | 2007 | 795 | 0.370 |
Why?
|
Adult | 98 | 2023 | 221203 | 0.360 |
Why?
|
Blood Pressure | 7 | 2019 | 8481 | 0.360 |
Why?
|
Movement Disorders | 3 | 2005 | 459 | 0.360 |
Why?
|
Female | 127 | 2023 | 392686 | 0.350 |
Why?
|
Algorithms | 20 | 2021 | 14032 | 0.340 |
Why?
|
Pattern Recognition, Automated | 4 | 2015 | 997 | 0.340 |
Why?
|
Middle Aged | 82 | 2023 | 220920 | 0.330 |
Why?
|
Interferon-beta | 4 | 2014 | 345 | 0.330 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2009 | 141 | 0.330 |
Why?
|
Delirium | 5 | 2019 | 1668 | 0.310 |
Why?
|
Internet | 1 | 2020 | 3093 | 0.310 |
Why?
|
Anisotropy | 5 | 2021 | 1283 | 0.310 |
Why?
|
Anatomy, Artistic | 1 | 2008 | 51 | 0.300 |
Why?
|
Mathematical Computing | 2 | 2006 | 142 | 0.300 |
Why?
|
Corpus Striatum | 1 | 2014 | 1235 | 0.300 |
Why?
|
Disability Evaluation | 13 | 2013 | 1836 | 0.300 |
Why?
|
Medical Illustration | 1 | 2008 | 135 | 0.290 |
Why?
|
Walking | 3 | 2011 | 1198 | 0.280 |
Why?
|
Gadolinium | 7 | 2020 | 960 | 0.280 |
Why?
|
Medulla Oblongata | 1 | 2008 | 248 | 0.280 |
Why?
|
Sensitivity and Specificity | 18 | 2017 | 14666 | 0.270 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2023 | 553 | 0.270 |
Why?
|
Cardiac Output | 1 | 2009 | 831 | 0.270 |
Why?
|
HLA Antigens | 2 | 2010 | 1328 | 0.260 |
Why?
|
Gadolinium DTPA | 4 | 2007 | 823 | 0.260 |
Why?
|
Depression | 4 | 2021 | 8124 | 0.260 |
Why?
|
Artifacts | 8 | 2008 | 1911 | 0.250 |
Why?
|
Macaca mulatta | 2 | 2008 | 2329 | 0.240 |
Why?
|
Information Management | 1 | 2005 | 100 | 0.230 |
Why?
|
Seasons | 1 | 2010 | 1520 | 0.230 |
Why?
|
Statistics as Topic | 3 | 2009 | 2358 | 0.220 |
Why?
|
Hypoxia, Brain | 1 | 2004 | 138 | 0.220 |
Why?
|
Friedreich Ataxia | 2 | 2013 | 77 | 0.210 |
Why?
|
Anxiety | 1 | 2017 | 4573 | 0.200 |
Why?
|
Severity of Illness Index | 18 | 2020 | 15843 | 0.200 |
Why?
|
Essential Tremor | 1 | 2024 | 157 | 0.200 |
Why?
|
Prospective Studies | 23 | 2023 | 54426 | 0.190 |
Why?
|
Nerve Degeneration | 1 | 2006 | 748 | 0.190 |
Why?
|
Cerebellum | 4 | 2018 | 1501 | 0.190 |
Why?
|
Brain Ischemia | 3 | 2016 | 3049 | 0.180 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26127 | 0.180 |
Why?
|
Aged, 80 and over | 26 | 2019 | 58986 | 0.180 |
Why?
|
Models, Neurological | 3 | 2010 | 1769 | 0.180 |
Why?
|
Central Nervous System | 2 | 2006 | 1336 | 0.180 |
Why?
|
Cerebrovascular Circulation | 5 | 2016 | 2727 | 0.180 |
Why?
|
Cerebral Veins | 2 | 2016 | 157 | 0.180 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 925 | 0.180 |
Why?
|
Brain Mapping | 14 | 2016 | 6635 | 0.180 |
Why?
|
Aged | 39 | 2019 | 169310 | 0.170 |
Why?
|
Contrast Media | 7 | 2020 | 5311 | 0.170 |
Why?
|
Cognition | 10 | 2020 | 6992 | 0.170 |
Why?
|
Follow-Up Studies | 21 | 2019 | 39107 | 0.170 |
Why?
|
Immunologic Factors | 5 | 2013 | 1589 | 0.160 |
Why?
|
Memory, Short-Term | 3 | 2023 | 982 | 0.160 |
Why?
|
Aquaporin 4 | 1 | 2019 | 161 | 0.150 |
Why?
|
Retinal Hemorrhage | 1 | 2018 | 95 | 0.150 |
Why?
|
Retinal Artery | 1 | 2018 | 109 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 1 | 2004 | 1432 | 0.140 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2010 | 1875 | 0.140 |
Why?
|
Speech | 1 | 2022 | 554 | 0.140 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 491 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 392 | 0.140 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2024 | 0.140 |
Why?
|
Wine | 1 | 2017 | 166 | 0.140 |
Why?
|
Hypertension | 4 | 2019 | 8540 | 0.140 |
Why?
|
Optic Nerve | 1 | 2020 | 572 | 0.140 |
Why?
|
Echo-Planar Imaging | 5 | 2007 | 663 | 0.130 |
Why?
|
Alzheimer Disease | 7 | 2022 | 8601 | 0.130 |
Why?
|
Heart Diseases | 1 | 2009 | 2781 | 0.130 |
Why?
|
Retrospective Studies | 16 | 2023 | 80646 | 0.130 |
Why?
|
Postoperative Complications | 5 | 2019 | 15633 | 0.130 |
Why?
|
Memory Disorders | 2 | 2016 | 1199 | 0.120 |
Why?
|
Confidentiality | 1 | 2019 | 609 | 0.120 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2002 | 1496 | 0.120 |
Why?
|
Urinary Incontinence | 2 | 2010 | 489 | 0.120 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 263 | 0.120 |
Why?
|
Middle Cerebral Artery | 2 | 2013 | 275 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2006 | 3575 | 0.120 |
Why?
|
Models, Biological | 2 | 2021 | 9469 | 0.120 |
Why?
|
Parietal Lobe | 3 | 2008 | 852 | 0.120 |
Why?
|
Nerve Fibers | 1 | 1998 | 708 | 0.120 |
Why?
|
Pyramidal Tracts | 1 | 2016 | 252 | 0.110 |
Why?
|
Cephalometry | 1 | 2016 | 382 | 0.110 |
Why?
|
Demyelinating Diseases | 1 | 2016 | 351 | 0.110 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2578 | 0.110 |
Why?
|
Stereotaxic Techniques | 1 | 1996 | 555 | 0.110 |
Why?
|
Models, Statistical | 5 | 2015 | 5079 | 0.110 |
Why?
|
Predictive Value of Tests | 12 | 2016 | 15266 | 0.110 |
Why?
|
Regression Analysis | 8 | 2015 | 6344 | 0.110 |
Why?
|
Dementia | 1 | 2008 | 2689 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2018 | 6228 | 0.100 |
Why?
|
Organ Size | 5 | 2017 | 2254 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 256 | 0.100 |
Why?
|
Mental Processes | 1 | 2013 | 244 | 0.100 |
Why?
|
HLA-B Antigens | 2 | 2010 | 317 | 0.100 |
Why?
|
Stroke | 3 | 2023 | 9758 | 0.100 |
Why?
|
Theory of Mind | 1 | 2013 | 91 | 0.100 |
Why?
|
Prognosis | 7 | 2016 | 29629 | 0.100 |
Why?
|
Young Adult | 17 | 2017 | 59255 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2004 | 3769 | 0.100 |
Why?
|
Thalamic Nuclei | 1 | 2012 | 111 | 0.100 |
Why?
|
Brain Diseases | 2 | 2018 | 1545 | 0.100 |
Why?
|
Microvessels | 1 | 2016 | 577 | 0.090 |
Why?
|
Psychomotor Performance | 2 | 2013 | 1882 | 0.090 |
Why?
|
Software | 4 | 2018 | 4434 | 0.090 |
Why?
|
Skull | 1 | 2016 | 818 | 0.090 |
Why?
|
Drug Substitution | 1 | 2014 | 290 | 0.090 |
Why?
|
Executive Function | 3 | 2019 | 1392 | 0.090 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 40 | 0.090 |
Why?
|
Cohort Studies | 10 | 2019 | 41493 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 5 | 2013 | 17904 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1613 | 0.090 |
Why?
|
Temporal Lobe | 2 | 2008 | 1695 | 0.090 |
Why?
|
Consensus | 2 | 2020 | 3123 | 0.090 |
Why?
|
Caudate Nucleus | 1 | 2012 | 390 | 0.090 |
Why?
|
Head | 1 | 1996 | 924 | 0.090 |
Why?
|
AIDS Dementia Complex | 1 | 2011 | 153 | 0.090 |
Why?
|
Normal Distribution | 2 | 2009 | 272 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2567 | 0.090 |
Why?
|
Reaction Time | 1 | 2016 | 2089 | 0.090 |
Why?
|
Motor Activity | 2 | 2016 | 2715 | 0.090 |
Why?
|
Facial Expression | 1 | 2013 | 508 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2007 | 1400 | 0.080 |
Why?
|
Cerebral Cortex | 5 | 2013 | 5779 | 0.080 |
Why?
|
Albuterol | 1 | 2010 | 213 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 602 | 0.080 |
Why?
|
Erythropoietin | 1 | 2013 | 719 | 0.080 |
Why?
|
Hippocampus | 3 | 2016 | 3766 | 0.080 |
Why?
|
Double-Blind Method | 7 | 2013 | 12341 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2895 | 0.080 |
Why?
|
Demography | 2 | 2013 | 1648 | 0.080 |
Why?
|
Disabled Persons | 2 | 2013 | 1225 | 0.080 |
Why?
|
Risk Factors | 12 | 2019 | 74213 | 0.070 |
Why?
|
Fuzzy Logic | 1 | 2007 | 57 | 0.070 |
Why?
|
Peptides | 2 | 2010 | 4358 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2009 | 504 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2012 | 4176 | 0.070 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2009 | 326 | 0.070 |
Why?
|
Reference Values | 5 | 2009 | 4920 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2009 | 1068 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 1972 | 0.070 |
Why?
|
Preoperative Care | 1 | 2016 | 2242 | 0.070 |
Why?
|
Blood-Brain Barrier | 4 | 2015 | 1027 | 0.070 |
Why?
|
Gene Frequency | 2 | 2010 | 3606 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2006 | 2547 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 629 | 0.070 |
Why?
|
Verbal Learning | 2 | 2009 | 463 | 0.070 |
Why?
|
Computational Biology | 1 | 2018 | 3517 | 0.070 |
Why?
|
Recurrence | 4 | 2021 | 8466 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2013 | 5247 | 0.060 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2005 | 11 | 0.060 |
Why?
|
Recovery of Function | 1 | 2016 | 2979 | 0.060 |
Why?
|
Time | 1 | 2007 | 546 | 0.060 |
Why?
|
Observer Variation | 3 | 2018 | 2606 | 0.060 |
Why?
|
Time Factors | 11 | 2020 | 39970 | 0.060 |
Why?
|
Vaccines, Subunit | 1 | 2005 | 161 | 0.060 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 897 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1003 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3905 | 0.060 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 40 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4028 | 0.060 |
Why?
|
Electromagnetic Fields | 1 | 2006 | 296 | 0.060 |
Why?
|
Perfusion | 1 | 2009 | 1373 | 0.060 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2850 | 0.060 |
Why?
|
HIV | 1 | 2011 | 1582 | 0.060 |
Why?
|
Quality of Life | 2 | 2017 | 13367 | 0.060 |
Why?
|
Calibration | 1 | 2006 | 818 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2005 | 623 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2632 | 0.060 |
Why?
|
beta-Lactams | 1 | 2005 | 155 | 0.060 |
Why?
|
Adolescent | 14 | 2016 | 88324 | 0.050 |
Why?
|
Dyspnea | 1 | 2011 | 1347 | 0.050 |
Why?
|
Apolipoprotein E4 | 1 | 2008 | 709 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2005 | 238 | 0.050 |
Why?
|
Age Distribution | 1 | 2009 | 2880 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1533 | 0.050 |
Why?
|
Alleles | 2 | 2010 | 6864 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2639 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2011 | 1897 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 172 | 0.050 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2005 | 343 | 0.050 |
Why?
|
Logistic Models | 6 | 2017 | 13255 | 0.050 |
Why?
|
Pilot Projects | 4 | 2022 | 8633 | 0.050 |
Why?
|
Information Dissemination | 2 | 2021 | 1126 | 0.050 |
Why?
|
Medication Adherence | 1 | 2014 | 2176 | 0.050 |
Why?
|
Linear Models | 4 | 2018 | 5872 | 0.050 |
Why?
|
Cerebral Arteries | 1 | 2004 | 490 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3306 | 0.050 |
Why?
|
Placebos | 2 | 2021 | 1667 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2421 | 0.050 |
Why?
|
Smoking | 2 | 2009 | 9053 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3461 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2009 | 1410 | 0.050 |
Why?
|
Monocytes | 2 | 2013 | 2570 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2005 | 363 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2691 | 0.050 |
Why?
|
Prevalence | 3 | 2019 | 15732 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2019 | 64684 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2008 | 953 | 0.050 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2013 | 281 | 0.050 |
Why?
|
Diffusion | 3 | 2015 | 814 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.040 |
Why?
|
Iron | 1 | 2009 | 1793 | 0.040 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2008 | 895 | 0.040 |
Why?
|
Adjuvants, Immunologic | 2 | 2010 | 1036 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4544 | 0.040 |
Why?
|
Hydroxyquinolines | 1 | 1999 | 17 | 0.040 |
Why?
|
Hand | 1 | 2005 | 903 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7391 | 0.040 |
Why?
|
Computer Simulation | 3 | 2009 | 6241 | 0.040 |
Why?
|
Databases as Topic | 1 | 2021 | 473 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2006 | 2707 | 0.040 |
Why?
|
Neurons | 2 | 2022 | 9463 | 0.040 |
Why?
|
Incidence | 4 | 2023 | 21355 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 760 | 0.040 |
Why?
|
Hemoglobin SC Disease | 1 | 1996 | 23 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 626 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1999 | 585 | 0.030 |
Why?
|
Erythrocytes | 2 | 1996 | 2413 | 0.030 |
Why?
|
Bone Marrow | 2 | 1999 | 2911 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 2 | 2006 | 1802 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3416 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3204 | 0.030 |
Why?
|
Laser Therapy | 2 | 1993 | 1092 | 0.030 |
Why?
|
Motor Cortex | 2 | 2003 | 1007 | 0.030 |
Why?
|
Acoustic Stimulation | 3 | 2005 | 1235 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2016 | 102 | 0.030 |
Why?
|
Phenotype | 3 | 2013 | 16592 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1126 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6312 | 0.030 |
Why?
|
Hydroxyurea | 1 | 1996 | 284 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2005 | 1796 | 0.030 |
Why?
|
Postural Balance | 1 | 2000 | 622 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1995 | 209 | 0.030 |
Why?
|
Amygdala | 1 | 2003 | 1354 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2011 | 4527 | 0.030 |
Why?
|
Meglumine | 1 | 1995 | 144 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1927 | 0.030 |
Why?
|
Electrodes | 1 | 1997 | 614 | 0.030 |
Why?
|
Age Factors | 4 | 2013 | 18398 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 1995 | 389 | 0.030 |
Why?
|
HIV Infections | 2 | 2011 | 17352 | 0.030 |
Why?
|
Phorbol Esters | 1 | 2013 | 108 | 0.030 |
Why?
|
Glioblastoma | 2 | 2019 | 3482 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5672 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1893 | 0.030 |
Why?
|
Animals | 7 | 2022 | 168467 | 0.030 |
Why?
|
Face | 1 | 2019 | 1026 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1336 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1750 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 12990 | 0.030 |
Why?
|
Body Fluid Compartments | 1 | 1992 | 50 | 0.030 |
Why?
|
Oxygen | 4 | 2005 | 4227 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 316 | 0.030 |
Why?
|
Gene Expression | 1 | 2005 | 7581 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 1995 | 647 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2006 | 10194 | 0.020 |
Why?
|
Accidental Falls | 1 | 2019 | 1068 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 2 | 2005 | 562 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3466 | 0.020 |
Why?
|
Comorbidity | 2 | 2019 | 10508 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2010 | 3162 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6484 | 0.020 |
Why?
|
Brain Edema | 1 | 1995 | 604 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 577 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 306 | 0.020 |
Why?
|
Knee Joint | 2 | 1999 | 1676 | 0.020 |
Why?
|
Axons | 1 | 2018 | 1674 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 140 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1574 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 22176 | 0.020 |
Why?
|
Arginine | 1 | 2013 | 934 | 0.020 |
Why?
|
Sex Factors | 2 | 2007 | 10553 | 0.020 |
Why?
|
Child | 4 | 2013 | 80156 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 1992 | 544 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2000 | 5485 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9541 | 0.020 |
Why?
|
Drug Combinations | 1 | 1995 | 2048 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2010 | 345 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30054 | 0.020 |
Why?
|
Lipids | 1 | 1999 | 3341 | 0.020 |
Why?
|
Interleukin-13 | 1 | 2010 | 392 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 411 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11121 | 0.020 |
Why?
|
Somatosensory Cortex | 2 | 2003 | 512 | 0.020 |
Why?
|
Urination | 1 | 2009 | 203 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 532 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1496 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1371 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2009 | 374 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 290 | 0.020 |
Why?
|
Social Behavior | 1 | 2013 | 1135 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10766 | 0.020 |
Why?
|
Entorhinal Cortex | 1 | 2008 | 287 | 0.020 |
Why?
|
Third Ventricle | 1 | 2007 | 74 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2013 | 957 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7407 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8830 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1814 | 0.020 |
Why?
|
Attention | 1 | 2016 | 2396 | 0.020 |
Why?
|
Complementarity Determining Regions | 1 | 2006 | 149 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4369 | 0.020 |
Why?
|
Immunologic Tests | 1 | 2006 | 104 | 0.020 |
Why?
|
Piperacillin | 1 | 2005 | 37 | 0.020 |
Why?
|
Ceftazidime | 1 | 2005 | 57 | 0.020 |
Why?
|
Central Nervous System Neoplasms | 1 | 1993 | 916 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2011 | 2571 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2012 | 1889 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 1994 | 1879 | 0.010 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18253 | 0.010 |
Why?
|
Area Under Curve | 1 | 2009 | 1638 | 0.010 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 597 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 1998 | 9031 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4280 | 0.010 |
Why?
|
Models, Structural | 1 | 2004 | 340 | 0.010 |
Why?
|
Genes, MHC Class II | 1 | 2005 | 434 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2007 | 916 | 0.010 |
Why?
|
Cephalosporins | 1 | 2005 | 198 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10212 | 0.010 |
Why?
|
Amoxicillin | 1 | 2005 | 180 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 966 | 0.010 |
Why?
|
Body Water | 2 | 1995 | 340 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2735 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22172 | 0.010 |
Why?
|
Odds Ratio | 2 | 2010 | 9646 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2006 | 662 | 0.010 |
Why?
|
Immune System | 1 | 2008 | 796 | 0.010 |
Why?
|
Mathematics | 1 | 2004 | 707 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2644 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2009 | 1115 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 980 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2846 | 0.010 |
Why?
|
Rotation | 1 | 2004 | 517 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1881 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4853 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15936 | 0.010 |
Why?
|
Individuality | 1 | 2004 | 301 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4793 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4352 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 819 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2927 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15501 | 0.010 |
Why?
|
Viral Load | 1 | 2011 | 3332 | 0.010 |
Why?
|
Electroencephalography | 1 | 1997 | 6237 | 0.010 |
Why?
|
Educational Status | 1 | 2009 | 2522 | 0.010 |
Why?
|
Dichotic Listening Tests | 1 | 2001 | 22 | 0.010 |
Why?
|
Cause of Death | 1 | 2011 | 3683 | 0.010 |
Why?
|
Hemodynamics | 1 | 2011 | 4160 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7237 | 0.010 |
Why?
|
Fingers | 1 | 2003 | 507 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3442 | 0.010 |
Why?
|
Phantoms, Imaging | 2 | 1999 | 2526 | 0.010 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2000 | 91 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1998 | 9280 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3688 | 0.010 |
Why?
|
Cues | 1 | 2005 | 875 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2011 | 2057 | 0.010 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 253 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20571 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8528 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2004 | 710 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6965 | 0.010 |
Why?
|
Memory | 1 | 2009 | 2193 | 0.010 |
Why?
|
Software Design | 1 | 1999 | 171 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9326 | 0.010 |
Why?
|
United States | 2 | 2018 | 72335 | 0.010 |
Why?
|
Spin Labels | 1 | 1999 | 337 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1998 | 228 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4575 | 0.010 |
Why?
|
Glioma | 1 | 1993 | 3455 | 0.010 |
Why?
|
Erythrocyte Aggregation | 1 | 1996 | 35 | 0.010 |
Why?
|
Movement | 1 | 2003 | 1479 | 0.010 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 1996 | 150 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12975 | 0.010 |
Why?
|
Arousal | 1 | 2001 | 1166 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 1996 | 201 | 0.010 |
Why?
|
Triethyltin Compounds | 1 | 1995 | 4 | 0.010 |
Why?
|
Ion Transport | 1 | 1996 | 319 | 0.010 |
Why?
|
Language | 1 | 2005 | 1540 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11904 | 0.010 |
Why?
|
Hydrogen | 1 | 1996 | 172 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12059 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2001 | 1866 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81533 | 0.010 |
Why?
|
Intraoperative Care | 1 | 1998 | 767 | 0.010 |
Why?
|
Hematocrit | 1 | 1996 | 623 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 42230 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2001 | 1420 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12463 | 0.010 |
Why?
|
Fetal Hemoglobin | 1 | 1996 | 345 | 0.010 |
Why?
|
Functional Laterality | 1 | 2001 | 2257 | 0.010 |
Why?
|
Extracellular Space | 1 | 1996 | 563 | 0.010 |
Why?
|
Water | 1 | 2000 | 1411 | 0.010 |
Why?
|
Chlorides | 1 | 1996 | 665 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1999 | 1702 | 0.010 |
Why?
|
PUVA Therapy | 1 | 1993 | 101 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2005 | 3826 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2005 | 5112 | 0.010 |
Why?
|
Lung | 1 | 2011 | 10002 | 0.010 |
Why?
|
Potassium | 1 | 1996 | 1311 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6180 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3810 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1993 | 826 | 0.010 |
Why?
|
Triglycerides | 1 | 1999 | 2461 | 0.010 |
Why?
|
Laser Coagulation | 1 | 1993 | 330 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10721 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12690 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23447 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1996 | 3088 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12794 | 0.010 |
Why?
|
Forecasting | 1 | 1999 | 2928 | 0.010 |
Why?
|
Hypothalamus | 1 | 1995 | 999 | 0.010 |
Why?
|
Neural Pathways | 1 | 2001 | 3060 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 1526 | 0.010 |
Why?
|
Radiosurgery | 1 | 1998 | 1342 | 0.000 |
Why?
|
Rabbits | 1 | 1995 | 4772 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1997 | 6019 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1994 | 2417 | 0.000 |
Why?
|
Fatty Acids | 1 | 1994 | 1808 | 0.000 |
Why?
|
Lipid Metabolism | 1 | 1994 | 1902 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4431 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1999 | 8002 | 0.000 |
Why?
|
Rats | 1 | 1993 | 23741 | 0.000 |
Why?
|